Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
Yahoo/BusinessWire
Saturday, August 31, 2013 - 11:13am
tags:
Genzyme, multiple sclerosis, Aubagio, MS
Should Novartis Shareholders Be Worried About This?
Motley Fool
Saturday, August 31, 2013 - 10:37am
tags:
Novarits, Gilenya, progressive multifocal leukoencephalopathy
Gilead Sues Merck Saying New Drug Won’t Infringe Patents
Seeking Alpha
Saturday, August 31, 2013 - 10:33am
tags:
patents, Merck, lawsuits, Gilead Sciences
Crowning the New King of Biotech
Motley Fool
Saturday, August 31, 2013 - 10:32am
tags:
Gilead Sciences
Data on Actelion's Opsumit Published
Yahoo/Zacks
Saturday, August 31, 2013 - 10:31am
tags:
Actelion, Opsumit, pulmonary arterial hypertension
Yes, Gilead Did It Again
Seeking Alpha
Saturday, August 31, 2013 - 10:29am
tags:
Gilead, sofosbuvir
Arena Week 11 Sales Up Big
Seeking Alpha
Saturday, August 31, 2013 - 10:28am
tags:
Arena
Trade-Ideas: Arena Pharmaceuticals (ARNA) Is Today's "Dead Cat Bounce" Stock
The Street
Saturday, August 31, 2013 - 10:27am
tags:
Arena
GTx: 4 Reasons Why This $1 Biotech Stock Could Be Poised For A Big Rebound
Seeking Alpha
Saturday, August 31, 2013 - 10:26am
tags:
GTx
Voluntary Recall at Cubist Pharma
Yahoo/Zacks
Saturday, August 31, 2013 - 10:25am
tags:
Cubist Pharmaceuticals, Cubicin, recalls
Pfizer’s Pipeline Story Begins to Unravel
Yahoo/YCharts
Friday, August 30, 2013 - 12:32pm
tags:
Pfizer, Eliquis, Xalkori, Xeljanz, Inlyta, Elelyso
Teva reports top-line results from Phase III study of NUVIGIL
The Fly on the Wall
Friday, August 30, 2013 - 12:27pm
tags:
Teva, NUVIGIL, bipolar disorder
The Impact of a Failed Crohn's Disease Trial Study
Motley Fool
Friday, August 30, 2013 - 10:36am
tags:
Crohn's Disease, Vercirnon, ChemoCentryx, GSK
Will Amgen's Purchase Of Onyx Prove To Be A Smart Move?
Seeking Alpha
Friday, August 30, 2013 - 10:02am
tags:
Amgen, M&A, ONYX Pharmaceuticals
FDA clears 3D-printed skull fillers by Tissue Regeneration Systems
Mass Device
Friday, August 30, 2013 - 9:36am
tags:
FDA, Tissue Regenerations Systems, skull fillers, devices
Novartis' MS drug Gilenya tied to rare brain infection
Fierce Pharma
Friday, August 30, 2013 - 9:32am
tags:
Novartis, Gilenya, MS, multiple sclerosis, PML, FDA
3 Biotech Stocks Under $10 to Watch
TheStreet.com
Friday, August 30, 2013 - 9:31am
tags:
Athersys, BioDelivery Sciences, Neuralstem
China Drug Probe Leads to Tougher Market, Ipsen CEO Says
Bloomberg
Friday, August 30, 2013 - 9:28am
tags:
China, Ipsen
Cubist Receives Antitrust Clearance for Trius Purchase
Motley Fool
Friday, August 30, 2013 - 8:52am
tags:
Trius Therapeutics, Cubist Pharmaceuticals, M&A
ThromboGenics Plunges on Jetrea Sales Forecast
Bloomberg
Friday, August 30, 2013 - 8:49am
tags:
ThromboGenics, Jetrea, vitreomacular adhesion

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.